A serious head-to-head Phase 2 study of the conjugate versus a cocktail of approved tirzepatide plus approved lanifibranor (assuming both reach the market) would settle this
These pipeline molecules sustain premium pricing and GLP-1 weight loss drug market demand growth through 2035
(48 placebo-controlled RCTs, 94,245 participants
Some human studies of high-dose IV vitamin C in patients with cancer have shown improved quality of life, as well as improvements in physical, mental, and emotional functions, symptoms of fatigue, nausea and vomiting, pain, and appetite loss
While these drugs were initially developed to manage diabetes, their increasing use for weight loss is altering consumer behavior in ways that could significantly impact the entire food supply chain
It was also proven that other -blockers (carvedilol, propranolol and atenolol) could potentially suppress dextrose-induced oxidative stress/endoplasmic reticulum stress and apoptosis in human coronary artery endothelial cells (Merken and Beecher, 2000